Entrada Therapeutics is a clinical-stage biopharmaceutical company focused on developing a new class of medicines for intracellular targets. They are advancing a portfolio of genetic medicines for neuromuscular and inherited retinal diseases. The company has a partnership with Vertex Pharmaceuticals for a clinical-stage program for myotonic dystrophy type 1 (DM1). Entrada anticipates significant clinical milestones in 2026, including multiple data readouts for their Duchenne muscular dystrophy (DMD) programs. They are seeking colleagues who are passionate, dedicated, and ready to make a significant impact on patients' lives.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal
Education Level
Ph.D. or professional degree